Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Omicron BA.2
Omicron BA.2
FDA halts Vir, GSK antibody use in response to COVID subvariant's spread
BioPharma Dive
Wed, 04/6/22 - 12:28 pm
FDA
GSK
Vir Biotechnology
antibodies
COVID-19
Omicron BA.2
FDA cuts off use of GSK's Covid treatment in almost half of the US as BA.2 spreads
Endpoints
Mon, 04/4/22 - 10:21 am
FDA
GSK
Vir Biotechnology
monoclonal antibodies
COVID-19
Omicron BA.2
Officials limit an antibody therapy, saying it’s ineffective against BA.2 variant of Omicron
Stat
Sun, 03/27/22 - 04:00 pm
Vir Biotechnology
GSK
monoclonal antibodies
sotrovimab
COVID-19
Omicron BA.2
FDA
AstraZeneca antibody drug effective against BA.2, study finds
Beckers Hospital Review
Mon, 03/21/22 - 10:37 pm
AstraZeneca
Evusheld
Omicron variant
Omicron BA.2
COVID-19
Early data indicate vaccines still protect against Omicron’s sister variant, BA.2
Stat
Sun, 01/30/22 - 11:38 am
vaccines
COVID-19
Omicron variant
Omicron BA.2